(Q51496446)

English

Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.

scientific article published in May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study. (English)

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

type 2 diabetes

0 references

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

Christopher D Byrne

5

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

author name string

R N Guzder

1

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

W Gatling

2

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

M A Mullee

3

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

R L Mehta

4

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

publication date

1 May 2005

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

Diabetic Medicine

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

22

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

554-562

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

5

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

Cardiovascular disease risk profiles.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

The Poole Diabetes Study: how many cases of Type 2 diabetes are diagnosed each year during normal health care in a defined community?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

An updated coronary risk profile. A statement for health professionals.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

Using the Framingham model to predict heart disease in the United Kingdom: retrospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01494.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2005.01494.X

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/15842509

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51496446&oldid=1629990226"